Argenica Therapeutic Receives $1.2m grant for traumatic brain injury project
- Argenica Therapeutics (AGN) receives a $1.2 million grant from the Australian Federal Government for traumatic brain injury (TBI) preclinical research
- The cash was awarded under the Cooperative Research Centre Project program, which matches funding for projects
- The project will see Argenica test the efficacy of its ARG-007 drug in preclinical animal models with mild repeated and moderate TBI
- Argenica, along with its collaboration partners, will be required to make up the remaining $1.5 million of the $2.7 million project
- AGN shares were up 4.49 per cent, trading at 46.5 cents at 11:40 am AEDT
